Healthcare information solutions provider Wolters Kluwer Health has announced a partnership with Philips Clinical Informatics TASY electronic health records (EHR) provider to improve ease of use and encourage greater adoption of medication decision support throughout Brazil. TASY is the first system used in Brazil to integrate Wolters Kluwer Clinical Drug Information drug data into its latest EHR release. With sophisticated drug data to power its medication, interactions and allergy screening functionality, TASY is creating an unprecedented advancement in efficiency in Brazilian healthcare.
Despite broad adoption of EHR solutions in Brazil, clinical decision support modules traditionally have not included the necessary drug data required to support screening functionality, forcing Brazilian pharmacists to build and enter their own drug information and interactions data. The newest TASY software offers up to eight clinical screening modules from Medi-Span®, an industry-leading Wolters Kluwer drug data solution. These include drug interactions, drug allergy, duplicate therapy, drug-disease contraindication, and dose range screening.
With a strong foundation of easy-to-implement drug data integrated within EHR functions, TASY customers will be able to employ medication decision support that is more extensive, more detailed, and more current than what is commonly available in Brazil.
